MARKER THERAPEUTICS, INC. Cash and Restricted Cash
MARKER THERAPEUTICS, INC. (MRKR) had Cash and Restricted Cash of $11.92 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11.92M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.64M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $17.04M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.94M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $11.92M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $15.64M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $17.04M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $18.94M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $11.81M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $13.69M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $19.19M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $9.00M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $7.80M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $11.32M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $15.11M 10-K · filed 2026-03-18 |
| 2023-09-30 | $17.47M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $18.12M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $6.40M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $11.78M 10-K · filed 2025-03-31 |
| 2022-09-30 | $18.08M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $25.82M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $28.82M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $43.50M 10-K · filed 2024-03-26 |
| 2021-09-30 | $48.71M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $57.22M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $64.51M 10-Q · filed 2022-05-13 |
| 2020-12-31 | $21.35M 10-K · filed 2023-03-22 |
| 2019-12-31 | $43.90M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |